Johnson & Johnson Stock (JNJ) Update: Shares Hold Near $208 as Markets Close for the Weekend; Eczema Trial Halt, Pipeline Wins, and 2026 Outlook in Focus ts2.tech Source link
Exeter Wins £3.3M Grant for Eczema Research Mirage News Source link
Dermavant’s storytelling platform turns kids’ eczema woes into wins MM+M Online Source link
On Jan. 14, AbbVie‘s (NYSE:ABBV) Rinvoq received approval from the U.S. Food and Drug Administration (FDA) to treat adults and children at least 12 years old with moderate-to-severe atopic dermatitis (eczema) whose condition didn’t respond to other medicines. What led the FDA to approve Rinvoq for its third indication? And how much of a boost […]